List of SBIR/STTR awards granted to Fannin Partners
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Fannin Partners in September, 2018 for $224,989.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG062064-01 | Phase I | 224,989 | September 30, 2018 | |||||||
A SBIR Phase II contract was awarded to Fannin Partners in August, 2018 for $999,993.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 7R44AI125007-03 | Phase II | 999,993 | August 20, 2018 | |||||||
A SBIR Phase I contract was awarded to Fannin Partners in September, 2019 for $224,771.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK123908-01 | Phase I | 224,771 | September 13, 2019 | |||||||
A SBIR Phase I contract was awarded to Fannin Partners in September, 2020 for $349,867.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DA053124-01 | Phase I | 349,867 | September 30, 2020 | |||||||
A SBIR Phase II contract was awarded to Fannin Partners in August, 2019 for $998,650.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HD094456-02 | Phase II | 998,650 | August 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Fannin Partners in July, 2021 for $993,974.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44OD030205-01 | Phase II | 993,974 | July 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Fannin Partners in August, 2022 for $299,921.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM143972-01A1 | Phase I | 299,921 | August 15, 2022 | |||||||
A SBIR Phase II contract was awarded to Fannin Partners in April, 2022 for $999,997.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA268530-01A1 | Phase II | 999,997 | April 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Fannin Partners in September, 2017 for $224,692.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK115336-01 | Phase I | 224,692 | September 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Fannin Partners in September, 2017 for $224,642.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD094456-01 | Phase I | 224,642 | September 21, 2017 | |||||||
A SBIR Phase I contract was awarded to Fannin Partners in August, 2017 for $243,014.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI131867-01 | Phase I | 243,014 | August 16, 2017 | |||||||
A SBIR Phase I contract was awarded to Fannin Partners in July, 2017 for $379,593.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43TR002043-01 | Phase I | 379,593 | July 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Fannin Partners in September, 2023 for $199,972.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration. | SBIR | 1R43FD007809-01 | Phase I | 199,972 | September 29, 2023 |
